In a randomized trial, withholding immunosuppression in patients with auto-inflammatory diseases did not lower the likelihood of progression to serious infection.
Compared with standard vaccine, high-dose vaccine had no relative effectiveness against influenza and pneumonia hospitalizations combined but did reduce influenza-specific hospitalizations in Denmark by 44%.